Pyxis Oncology Filter Stocks by Fundamentals

PYXS Stock

USD 2.30 0.47 25.68%

Pyxis Oncology's Net Income breaks down into its formula components alongside the latest figure. The current level reflects data from the most recent disclosure cycle.

null

The current Net Income for Pyxis Oncology reflects the latest reporting cycle. The displayed period depends on the company's disclosure schedule.

Did You Try This?

Run Portfolio Manager Now

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital

All Next

Launch Module

Important Fundamentals

	Return On Equity TTM	-0.91
	Return On Asset TTM	-0.41
	Operating Margin TTM	-1.59
	Current Valuation	62.44 M
	Shares Outstanding	62.86 M
	Shares Owned By Insiders	22.30 %
	Shares Owned By Institutions	37.57 %
	Number Of Shares Shorted	2.27 M
	Price To Book TTM	2.02 X
	Price To Sales TTM	7.98 X
	Revenue TTM	13.86 M
	Gross Profit TTM	11.47 M
	EBITDA TTM	-79.91 M
	Net Income TTM	-79.62 M
	Cash And Equivalents TTM	223.36 M
	Cash Per Share TTM	7.48 X
	Total Debt TTM	18.67 M
	Debt To Equity TTM	0.07 %
	Current Ratio TTM	15.19 X
	Book Value Per Share TTM	0.85 X
	Cash Flow From Operations TTM	-63.5 M
	Short Ratio TTM	5.92 X
	Earnings Per Share	-1.31 X
	Price To Earnings To Growth	0.01 X
	Target Price	6.88
	Number Of Employees	56
	Trailing Beta	1.43
	Market Capitalization TTM	110.63 M
	Total Asset TTM	91.52 M
	Retained Earnings TTM	-443.18 M
	Working Capital TTM	50.97 M
	Net Asset	91.52 M

Financial Metrics, Fundamentals & Methodology

Pyxis Oncology's operating framework helps explain margin behavior, earnings persistence, and funding capacity. The company is currently operating at a loss. Overall market capitalization tier is micro-cap. In recent filings, Pyxis Oncology reported revenue of 13.86 million, EPS loss of 1.31, negative operating margin of 1.59% as of the latest reporting period.

Pyxis Oncology metrics draw on periodic company reporting and market reference feeds, standardized for cross-period comparison. Reported income, balance-sheet, and cash-flow fields adhere to GAAP or IFRS presentation rules.

Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board